[unable to retrieve full-text content]Reuters - A renewed push by the central government to expand healthcare reforms and restrict costs for end users is putting pressure on margins for a growing number of Chinese drugmakers.
Source: http://us.rd.yahoo.com/dailynews/rss/china/*http%3A//news.yahoo.com/s/nm/20120302/hl_nm/us_china_pharma_outlook
portland news portland news tibetan mastiff manny pacquiao pacquiao blanche blanche
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.